Transitional Cell Carcinoma
Oncology
2
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
1
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Pierre FabreFrance - Aignan
2 programs1
vinfluninePhase 2
JAVLOR® Online Non-Interventional TrialN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
CG OncologyCG0070 Adenovirus Vector
Pierre FabreJAVLOR® Online Non-Interventional Trial
Clinical Trials (2)
Total enrollment: 200 patients across 2 trials
Efficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder Cancer
Start: Mar 2014Est. completion: Jun 2016
Phase 2/3Terminated
JAVLOR® Online Non-Interventional Trial
Start: Apr 2010Est. completion: Aug 2013200 patients
N/ACompleted
Related Jobs in Oncology
Senior Research Associate, Immuno-Oncology
SystImmune
1h ago
$60K - $85K/yr
Research Associate I/II, Immuno-Oncology
SystImmune
1h ago
Office Administrator
SystImmune
1h ago
$60K - $80K/yr
Scientist/Sr Scientist
TwoStep Therapeutics
San Carlos
1h ago
Senior Medical Project Manager (m/f/d)
Mindpeak
Hamburg
1h ago
Working Student Active Sourcing Support (m/f/d)
Mindpeak
Hamburg
1h ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space